Clinical Trial Update: The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lansoprazole for infants with gastroesophageal reflux symptoms has completed; sponsor Takeda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: COMPLETED